Analystreport

ImmunoGen, Inc. (NASDAQ: IMGN) had its "buy" rating re-affirmed by analysts at HC Wainwright.

ImmunoGen, Inc.  (IMGN) 
Last immunogen, inc. earnings: 5/1 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.immunogen.com/investor-relations